PTGS2 and breast carcinoma: This pathway was shown to uncouple TGF-β from Smad 2/3 signaling in COX-2 expressing breast cancer cells explaining the switch of TGF-β from a tumor-suppressor to a tumor-promoter during mammary carcinogenesis52.